7-(3-Bromo-4-methoxybenzyl)-1-ethyl-8-(((1R,2R)-2-hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-3,7-dihydro-1H-purine-2,6-dione

CAS: 569351-91-3

Ref. 3D-UXA35191

Produktinformation

• Name: 7-(3-Bromo-4-methoxybenzyl)-1-ethyl-8-(((1R,2R)-2-hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-3,7-dihydro-1H-purine-2,6-dione
• Marke: Biosynth
• Beschreibung: The carbonic anhydrase inhibitor acetazolamide (Diamox) is a drug that inhibits the enzyme carbonic anhydrase. Acetazolamide is used for the treatment of glaucoma, epilepsy, and in some cases of altitude sickness. Inhibition of carbonic anhydrase leads to a build-up of bicarbonate ions and thus increased blood levels of CO2. This can lead to a number of symptoms including fatigue, nausea, vomiting, dizziness, headache, mental confusion, and kidney problems. Acetazolamide has been shown to be effective against prostate hyperplasia and may be able to alleviate certain symptoms associated with this condition. It may also be effective against angina pectoris caused by cardiac disease by inhibiting phosphodiesterases that break down cGMP in the heart.

Chemische Eigenschaften

• Molekulargewicht: 522.4 g/mol
• Formel: C₂₂H₂₈BrN₅O₅
• Reinheit: Min. 95%